Kverno KS, Mangano E (2021) Treatment-resistant depression: approaches to treatment. J Psychosoc Nurs Ment Health Serv 59:7–11. https://doi.org/10.3928/02793695-20210816-01
Voineskos D, Daskalakis ZJ, Blumberger DM (2020) Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat 16:221–234. https://doi.org/10.2147/ndt.S198774
Article PubMed PubMed Central CAS Google Scholar
Vlaicu A, Bustuchina Vlaicu M (2020) New neuromodulation techniques for treatment resistant depression. Int J Psychiatry Clin Pract 24:106–115. https://doi.org/10.1080/13651501.2020.1728340
Cheng CM, Li CT, Tsai SJ (2021) Current updates on newer forms of transcranial magnetic stimulation in major depression. Adv Exp Med Biol 1305:333–349. https://doi.org/10.1007/978-981-33-6044-0_18
Article PubMed CAS Google Scholar
Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM (2010) Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 27:960–963. https://doi.org/10.1002/da.20731
Article PubMed PubMed Central Google Scholar
Sverak T, Ustohal L (2018) Efficacy and safety of intensive transcranial magnetic stimulation. Harv Rev Psychiatry 26:19–26. https://doi.org/10.1097/hrp.0000000000000151
Baeken C (2018) Accelerated rTMS: a potential treatment to alleviate refractory depression. Front Psychol 9:2017. https://doi.org/10.3389/fpsyg.2018.02017
Article PubMed PubMed Central Google Scholar
Sonmez AI, Camsari DD, Nandakumar AL, Voort JLV, Kung S, Lewis CP, Croarkin PE (2019) Accelerated TMS for depression: a systematic review and meta-analysis. Psychiatry Res 273:770–781. https://doi.org/10.1016/j.psychres.2018.12.041
Wang Q, Huang H, Li D, Wang Y, Qi N, Ci Y, Xu T (2022) Intensive rTMS for treatment-resistant depression patients with suicidal ideation: an open-label study. Asian J Psychiatr 74:103189. https://doi.org/10.1016/j.ajp.2022.103189
Wang Q, Huang H, Xu T, Dong X (2023) Intensive rTMS treatment for non-suicidal self-injury in an adolescent treatment-resistant depression patient: a case report. Asian J Psychiatr 88:103740. https://doi.org/10.1016/j.ajp.2023.103740
Wang Q, Huang H, Xu T (2022) Intensive rTMS for a treatment-resistant bipolar depression patient with serious suicidal ideation: a case report. Asian J Psychiatr 71:103079. https://doi.org/10.1016/j.ajp.2022.103079
Lacroix A, Calvet B, Laplace B, Lannaud M, Plansont B, Guignandon S, Balestrat P, Girard M (2021) Predictors of clinical response after rTMS treatment of patients suffering from drug-resistant depression. Transl Psychiatry 11:587. https://doi.org/10.1038/s41398-021-01555-9
Article PubMed PubMed Central CAS Google Scholar
Li CT, Su TP, Cheng CM, Chen MH, Bai YM, Tsai SJ (2022) Factors associated with antidepressant responses to repetitive transcranial magnetic stimulation in antidepressant-resistant depression. Front Neurosci 16:1046920. https://doi.org/10.3389/fnins.2022.1046920
Article PubMed PubMed Central Google Scholar
Poleszczyk A, Rakowicz M, Parnowski T, Antczak J, Święcicki Ł (2018) Are there clinical and neurophysiologic predictive factors for a positive response to HF-rTMS in patients with treatment-resistant depression? Psychiatry Res 264:175–181. https://doi.org/10.1016/j.psychres.2018.03.084
Li X, Yu C, Ding Y, Chen Z, Zhuang W, Liu Z, Fan J, Yan H, Xu W, Zhu G, Zhang X, Zhou D (2023) Motor cortical plasticity as a predictor of treatment response to high frequency repetitive transcranial magnetic stimulation (rTMS) for cognitive function in drug-naive patients with major depressive disorder. J Affect Disord 334:180–186. https://doi.org/10.1016/j.jad.2023.04.085
Article PubMed CAS Google Scholar
Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA (2012) Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety 29:587–596. https://doi.org/10.1002/da.21969
Ciobanu C, Girard M, Marin B, Labrunie A, Malauzat D (2013) rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age. J Affect Disord 150:677–681. https://doi.org/10.1016/j.jad.2013.03.024
Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, Gilmer W, Marangell LB, Aaronson S, Daskalakis ZJ, Canterbury R, Richelson E, Sackeim HA, George MS (2009) Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34:522–534. https://doi.org/10.1038/npp.2008.118
Meshkat S, Alnefeesi Y, Jawad MY, Ceban JDDVNBR, Mw Lui F, McIntyre L, Rosenblat RS JD (2022) Brain-derived neurotrophic factor (BDNF) as a biomarker of treatment response in patients with treatment resistant depression (trd): a systematic review & meta-analysis. Psychiatry Res 317:114857. https://doi.org/10.1016/j.psychres.2022.114857
Article PubMed CAS Google Scholar
Wang Q, Zeng L, Hong W, Luo M, Zhao N, Hu X, Shi M, Qiu J, Shen Y, Teng X, Min H, Liu W (2022) Inflammatory cytokines changed in patients with depression before and after repetitive transcranial magnetic stimulation treatment. Front Psychiatry 13:925007. https://doi.org/10.3389/fpsyt.2022.925007
Article PubMed PubMed Central Google Scholar
Zheng Y, Yin K, Li L, Wang X, Li H, Li W, Fang Z (2024) Association between immune-inflammation-based prognostic index and depression: an exploratory cross-sectional analysis of nhanes data. J Affect Disord 362:75–85. https://doi.org/10.1016/j.jad.2024.06.103
Article PubMed CAS Google Scholar
Lobbestael J, Leurgans M, Arntz A (2011) Inter-rater reliability of the structured clinical interview for dsm-iv axis I disorders (SCID I) and axis II disorders (SCID II). Clin Psychol Psychother 18:75–79. https://doi.org/10.1002/cpp.693
Fogelson DL, Leuchter A (2017) Defining treatment-resistant depression. JAMA Psychiatry 74:758–759. https://doi.org/10.1001/jamapsychiatry.2017.0967
Hellmann-Regen J, Clemens V, Grözinger M, Kornhuber J, Reif A, Prvulovic D, Goya-Maldonado R, Wiltfang J, Gruber O, Schüle C, Padberg F, Ising M, Uhr M, Friede T, Huber C, Manook A, Baghai TC, Rupprecht R, Heuser I (2022) Effect of minocycline on depressive symptoms in patients with treatment-resistant depression: a randomized clinical trial. JAMA Netw Open 5:e2230367. https://doi.org/10.1001/jamanetworkopen.2022.30367
Article PubMed PubMed Central Google Scholar
Meng L, Yang Y, Hu X, Zhang R, Li X (2023) Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med 21:79. https://doi.org/10.1186/s12967-023-03924-y
Article PubMed PubMed Central Google Scholar
Karimi A, Shobeiri P, Kulasinghe A, Rezaei N (2021) Novel systemic inflammation markers to predict covid-19 prognosis. Front Immunol 12:741061. https://doi.org/10.3389/fimmu.2021.741061
Article PubMed PubMed Central CAS Google Scholar
Nicoară DM, Munteanu AI, Scutca AC, Mang N, Juganaru I, Brad GF, Mărginean O (2023) Assessing the relationship between systemic immune-inflammation index and metabolic syndrome in children with obesity. Int J Mol Sci 24:8414. https://doi.org/10.3390/ijms24098414
Article PubMed PubMed Central CAS Google Scholar
Mi Z, Biswas K, Fairchild JK, Davis-Karim A, Phibbs CS, Forman SD, Thase M, Georgette G, Beale T,
留言 (0)